DE2028224A1 - Oral anwendbare Arzneimittelform - Google Patents
Oral anwendbare ArzneimittelformInfo
- Publication number
- DE2028224A1 DE2028224A1 DE19702028224 DE2028224A DE2028224A1 DE 2028224 A1 DE2028224 A1 DE 2028224A1 DE 19702028224 DE19702028224 DE 19702028224 DE 2028224 A DE2028224 A DE 2028224A DE 2028224 A1 DE2028224 A1 DE 2028224A1
- Authority
- DE
- Germany
- Prior art keywords
- effect
- active ingredients
- active ingredient
- tablet
- form according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims description 10
- 229940079593 drug Drugs 0.000 title claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 25
- 230000000694 effects Effects 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 6
- 210000004051 gastric juice Anatomy 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 230000002496 gastric effect Effects 0.000 claims description 2
- 210000004789 organ system Anatomy 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims 3
- KLYCPFXDDDMZNQ-UHFFFAOYSA-N Benzyne Chemical group C1=CC#CC=C1 KLYCPFXDDDMZNQ-UHFFFAOYSA-N 0.000 claims 2
- 230000000968 intestinal effect Effects 0.000 claims 2
- 239000007942 layered tablet Substances 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 239000008187 granular material Substances 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 230000001813 broncholytic effect Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- -1 ester hydrochloride Chemical class 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH878369 | 1969-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2028224A1 true DE2028224A1 (de) | 1970-12-17 |
Family
ID=4344698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19702028224 Pending DE2028224A1 (de) | 1969-06-10 | 1970-06-09 | Oral anwendbare Arzneimittelform |
Country Status (3)
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2453649A1 (fr) * | 1978-12-15 | 1980-11-07 | Lehner Ag | Composition pharmaceutique a action prolongee contenant des acides biliaires utile notamment pour la lyse des calculs |
| EP0013131A3 (en) * | 1978-12-27 | 1981-01-07 | Mundipharma A.G. | Pharmaceutical composition in solid dosage form, and process for its production |
| FR2601589A1 (fr) * | 1986-05-27 | 1988-01-22 | Ciba Geigy Ag | Supplement dietetique a plusieurs vitamines et plusieurs mineraux contenant du fer biodisponible a liberation controlee |
| EP0361910A1 (en) * | 1988-09-30 | 1990-04-04 | Rhone Poulenc Rorer Limited | Granular pharmaceutical formulations |
| US5629003A (en) * | 1990-06-07 | 1997-05-13 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Rapidly disintegrating sheet-like presentations of multiple dosage units |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2537434A1 (fr) * | 1982-12-09 | 1984-06-15 | Sandoz Sa | Composition pharmaceutique d'endralazine sous forme retard |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL122039C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1960-10-20 |
-
1970
- 1970-06-09 DE DE19702028224 patent/DE2028224A1/de active Pending
- 1970-06-10 FR FR7021261A patent/FR2052946B1/fr not_active Expired
- 1970-06-10 GB GB2807970A patent/GB1302266A/en not_active Expired
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2453649A1 (fr) * | 1978-12-15 | 1980-11-07 | Lehner Ag | Composition pharmaceutique a action prolongee contenant des acides biliaires utile notamment pour la lyse des calculs |
| EP0013131A3 (en) * | 1978-12-27 | 1981-01-07 | Mundipharma A.G. | Pharmaceutical composition in solid dosage form, and process for its production |
| FR2601589A1 (fr) * | 1986-05-27 | 1988-01-22 | Ciba Geigy Ag | Supplement dietetique a plusieurs vitamines et plusieurs mineraux contenant du fer biodisponible a liberation controlee |
| BE1000434A5 (fr) * | 1986-05-27 | 1988-12-06 | Ciba Geigy | Supplement dietetique a plusieurs vitamines et plusieurs mineraux contenant du fer biodisponible a liberation controlee. |
| EP0361910A1 (en) * | 1988-09-30 | 1990-04-04 | Rhone Poulenc Rorer Limited | Granular pharmaceutical formulations |
| US5489439A (en) * | 1988-09-30 | 1996-02-06 | May & Baker Ltd. | Granular pharmaceutical formulations |
| US5629003A (en) * | 1990-06-07 | 1997-05-13 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Rapidly disintegrating sheet-like presentations of multiple dosage units |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2052946A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1971-04-16 |
| FR2052946B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-01-10 |
| GB1302266A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1973-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69826113T2 (de) | R- und s- enantiomere getrennteteile enthaltende dosierungsformen | |
| DE69429826T3 (de) | Opioid-formulierungen zur schmerzbehandlung | |
| EP0938316B1 (de) | Opioidantagonisthaltige galenische formulierung | |
| EP1183015B1 (de) | Mehrschichttablette zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| DE69432618T2 (de) | Arzneimittel mit gesteuertem Beginn und gesteuerter Rate der Freisetzung | |
| EP0979069B1 (de) | Verfahren zur herstellung peroral anwendbarer fester arzneiformen mit gesteuerter wirkstoffabgabe | |
| DE69315257T2 (de) | Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen | |
| DE69920689T2 (de) | Vorrichtungen zum Aufrechterhalten eines gewünschten therapeutischen Medikamenteneffekts über einen verlängerten Therapiezeitraum | |
| DE69802543T2 (de) | Verbesserte multipartikel-tablette mit schnellauflösbarkeit | |
| DE69230112T2 (de) | Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin | |
| DE20308436U1 (de) | Lagerstabiles pharmazeutisches Präparat, das Oxycodon und Naloxon umfasst | |
| DE69526467T2 (de) | Arzneizubereitungen für die verlängerte Trimetazidinfreisetzung nach oraler Verabreichnung | |
| AT9895U1 (de) | Verfahren zur behandlung von viszeralem schmerz | |
| DE60317993T2 (de) | Pharmazeutische Zubereitung mit verzögerter Freisetzung zur oralen Wirkstoffverabreichung | |
| DE4303846A1 (de) | Verfahren zur Herstellung einer S-Ibuprofen enthaltenden Tablette | |
| DE60034373T2 (de) | Methode und zusammensetzung zur behandlung von resistenz gegen antihypertensiva und verwandten zuständen | |
| DE2028224A1 (de) | Oral anwendbare Arzneimittelform | |
| DE112014005175T5 (de) | Hydromorphon und Naloxon für die Behandlung von Schmerzen und Opioid-Darm-Dysfunktions-Syndrom | |
| EP1844779A2 (de) | Tergurid/Protergurid zur Behandlung von chronischen Schmerzen (z.B. Migräne) | |
| DE2343218A1 (de) | Zubereitungsformen von n-(2-furfuryl)4-chlor-5-sulfamoylanthranilsaeure und verfahren zu ihrer herstellung | |
| DE2359128A1 (de) | Arzneimittel auf basis von lisurid und dessen physiologisch vertraeglichen salzen | |
| DE602004005734T2 (de) | Pharmazeutische zusammensetzung mit kontrollierter freisetzung und verfahren zu ihrer herstellung | |
| DE2260384C3 (de) | Oral zu applizierendes Corticosteroid-Präparat | |
| DE69021224T2 (de) | Erosionsgesteuertes Freisetzungssystem für Wirkstoffe sowie Verfahren zu dessen Herstellung. | |
| EP0667151B1 (de) | Orale Arzeimittelzubereitung enthaltend Diclofenac-Natrium und eine organische Säure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SH | Request for examination between 03.10.1968 and 22.04.1971 | ||
| OHN | Withdrawal |